✦ LIBER ✦
398 POSTER Phase I, pharmacokinetic (PK), dose-escalation study of EZN-2968, a novel hypoxia-inducible factor-1 alpha (HIF-1a) antagonist, administered weekly in patients (pts) with solid tumours
✍ Scribed by N. Lewis; R.B. Cohen; Y. Nishida; H.I. Hurwitz; C. Arrowwood; H.E. Uronis; F. Gamza; C. Longley; A. Buchbinder; J. Figueroa
- Book ID
- 119599554
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 61 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.